Corrigendum: Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K–AKT Pathway and Activating the AMPK–ROS Pathway
Xuan Wei, Juanjuan Shi, Qianhan Lin, Xiaoxue Ma, Yingxin Pang, Hongluan Mao, Rui Li, Wei Lü, Yu Wang, Peishu Liu
Abstract
Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K-AKT Pathway and Activating the AMPK-ROS Pathway [email protected] the original article, there was a mistake in "FIGURE 5B" as published. We recognized by ourself that the picture of "PI3K" was the same as that of "pan-AKT", we made a mistake when we dragged the original figure into the AI software. The corrected "FIGURE 5B" appears below. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. We offered the original pictures of three independent experiments in the additional files for the editor to check. The original article has been updated.